Travere Therapeutics
TVTX
TVTX
65 hedge funds and large institutions have $265M invested in Travere Therapeutics in 2014 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 30 increasing their positions, 16 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
61% more capital invested
Capital invested by funds: $165M → $265M (+$101M)
8% more funds holding
Funds holding: 60 → 65 (+5)
Holders
65
Holding in Top 10
3
Calls
$3.55M
Puts
$48K
Top Buyers
| 1 | +$12.4M | |
| 2 | +$10.4M | |
| 3 | +$6.87M | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$4.83M |
| 5 |
SAM
Senzar Asset Management
New York
|
+$4.2M |
Top Sellers
| 1 | -$12.6M | |
| 2 | -$3.11M | |
| 3 | -$1.37M | |
| 4 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$1.08M |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$979K |